![]() α-Conotoxin Im-I structure
|
Common Name | α-Conotoxin Im-I | ||
---|---|---|---|---|
CAS Number | 156467-85-5 | Molecular Weight | 1351.561 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C52H78N20O15S4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of α-Conotoxin Im-Iα-Conotoxin Im-I is a selective α7/α9 nAChR antagonist, blocking α7 nicotinic receptors with the highest apparent affinity, while having an 8-fold lower affinity for homomeric α9 nicotinic receptors. α-Conotoxin Im-I is toxic and induces seizures in rodents. α-Conotoxin Im-I is a tool for studying neuronal nAChR[1][2]. |
Name | [(1R,4S,7S,13S,16S,19R,24R,27S,30S,33S,40R)-4,27-Bis(3-carbamimidamidopropyl)-24-carbamoyl-40-(glycylamino)-16-(hydroxymethyl)-30-(1H-indol-3-ylmethyl)-33-methyl-3,6,12,15,18,26,29,32,35,41-decaoxo-21,22,37,38-tetrathia-2,5,11,14,17,25,28,31,34,42-decaazatricyclo[17.16.7.07,11]dotetracont-13-yl]acetic acid |
---|---|
Synonym | More Synonyms |
Description | α-Conotoxin Im-I is a selective α7/α9 nAChR antagonist, blocking α7 nicotinic receptors with the highest apparent affinity, while having an 8-fold lower affinity for homomeric α9 nicotinic receptors. α-Conotoxin Im-I is toxic and induces seizures in rodents. α-Conotoxin Im-I is a tool for studying neuronal nAChR[1][2]. |
---|---|
Related Catalog | |
Target |
α7/α9 nAChR[1][2]. |
Density | 1.7±0.1 g/cm3 |
---|---|
Molecular Formula | C52H78N20O15S4 |
Molecular Weight | 1351.561 |
Exact Mass | 1350.483887 |
LogP | -7.80 |
Index of Refraction | 1.770 |
[(1R,4S,7S,13S,16S,19R,24R,27S,30S,33S,40R)-4,27-Bis(3-carbamimidamidopropyl)-24-carbamoyl-40-(glycylamino)-16-(hydroxymethyl)-30-(1H-indol-3-ylmethyl)-33-methyl-3,6,12,15,18,26,29,32,35,41-decaoxo-21 ;,22,37,38-tetrathia-2,5,11,14,17,25,28,31,34,42-decaazatricyclo[17.16.7.07,11]dotetracont-13-yl]acetic acid |
23,6-(Iminopropanodithiomethano)-1H,22H-pyrrolo[2,1-v][1,2,5,8,11,14,17,20,23,26,29]dithianonaazacyclodotriacontine-29-acetic acid, 37-[(2-aminoacetyl)amino]-18-(aminocarbonyl)-3,15-bis[3-[(aminoiminomethyl)amino]propyl]triacontahydro-26-(hydroxymethyl)-12-(1H-indol-3-ylmethyl)-9-methyl-1,4,7,10,13,16,24,27,30,36-decaoxo-, (3S,6R,9S,12S,15S,18R,23R,26S,29S,34aS,37R)- |